Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 million Series B at a valuation of $1.64 billion led by Kleiner Perkins, the company announced Thursday. The funding comes nine months after Hippocratic AI raised a $53 million round from General Catalyst and Andreessen Horowitz and five months after raising $17 million from Nvidia. The startup is less than two years old.
While most healthcare-generative AI companies focus on reducing administrative burdens, Hippocratic AI addresses the shortage of healthcare professionals by creating agents that can perform simple tasks like pre-operating procedures, remote patient monitoring, and appointment preparation.
In 2024, the startup has signed contracts with 23 health systems and insurers. Hippocratic is using new capital to expand the product into more markets and internationally.
